The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...

MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia ...

The trial, called Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT), found that radiofrequency (RF) ablation guided by electroanatomic mapping of the ...

In a "strong statements and controversies" session at the European Heart Rhythm Association (EHRA) EUROPACE-CARDIOSTIM 2017 meeting, Prof Gerhard Hindricks (University of Leipzig, Germany) said ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

(MENAFN- AETOSWire) (BUSINESS WIRE )-- Imricor Medical Systems, Inc. ( Company or Imricor) ( ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the ...